Vital Signs Archives | Page 4 of 121

Madison Snyder, 2nd-year UNC School of Medicine med student and 2025-26 NC Schweitzer Fellow, pens op-ed about how skin cancer can affect a variety of skin tones.

In fiscal year 2025, UNC School of Medicine researchers led the drive toward important discoveries aimed at improving human health and the lives of people in North Carolina. Our researchers remain dedicated to UNC’s broader research missions by preventing and curing disease, optimizing brain health and well-being, and applying artificial intelligence to benefit and save lives.

The research, led by Nobel laureate and biochemist Aziz Sancar, MD, PhD, could revolutionize treatments for glioblastoma, an aggressive and deadly form of brain cancer.

A new study in the lab of Jason Stein, PhD, modeled brain development in a dish to identify cells and genes that influence infant brain growth, a trait associated with autism.

This project is co-led by Dual Principal Investigators Dr. Kori Flower at the University of North Carolina at Chapel Hill and Dr. Eliana Perrin at The Johns Hopkins University.

A clinical trial led by the UNC School of Medicine weighs medications versus ‘wait and see’ approach for treatment of patent ductus arteriosus.

Dissociation of G protein from drug-bound GPCR (orange) is captured in accelerated molecular dynamics simulations, starting from the bound (blue) to free state (red), with a trace of its C-terminal residue colored in a blue-white-red scale.

UNC researchers discovered how a key step in cell signaling works by showing exactly how G proteins detach from receptors that many common medicines target.

Carter, who has led record-breaking innovation growth at UNC-Chapel Hill since 2023, will advance medical and healthcare commercialization and entrepreneurship across the UNC School of Medicine UNC Health system starting December 2025.

The society recognizes distinguished academic leaders, educators, and researchers whose contributions have earned national and international acclaim.

Breathing wildfire smoke, even briefly, can change the bacteria and immune cells in your lungs, which may contribute to adverse health effects.

UNC School of Medicine researchers led an international clinical trial of patients with generalized myasthenia gravis, finding the therapy is safe and effective across all subtypes.

Researchers found that inhibiting a problematic protein in the body helps immunotherapies and CAR T-cell therapy to better fight off melanoma.

Category: Vital Signs

Snyder Pens Op-Ed About How Skin Cancer Doesn’t Care What Color You Are

The Year in Research

UNC Researchers Show Combination Therapy Effective for Brain Cancer

UNC Researchers Build Stem Cell Models to Mimic Early Brain Development

UNC Awarded Funding To Implement Useful Research Results to Prevent Childhood Obesity

UNC Study Confirms Early Use of Medications May Lead to Life-Threatening Conditions in Preterm Infants with Heart Defect

UNC Scientists Discover How a Critical Signaling Step Works Inside Cells

Dedric Carter named Vice President for Commercialization and Translational Advancement at UNC Health

Bauserman Elected Member of American Pediatric Society

UNC Researchers Uncover Wildfire Smoke’s Impact on Respiratory Health

UNC Study Supports Wider Use of FDA-Approved Drug for Rare Muscle Disease

UNC Researchers Unlock New Way to Help Fight Skin Cancer